- Home
- XRTX vs ERNA Comparison
XRTX vs ERNA Comparison
Compare XRTX & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- ERNA
- Stock Information
- Founded
- XRTX 2011
- ERNA 2018
- Country
- XRTX Canada
- ERNA United States
- Employees
- XRTX N/A
- ERNA N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- XRTX Health Care
- ERNA Health Care
- Exchange
- XRTX Nasdaq
- ERNA Nasdaq
- Market Cap
- XRTX 5.0M
- ERNA 5.5M
- IPO Year
- XRTX N/A
- ERNA N/A
- Fundamental
- Price
- XRTX $1.82
- ERNA $1.07
- Analyst Decision
- XRTX Strong Buy
- ERNA
- Analyst Count
- XRTX 1
- ERNA 0
- Target Price
- XRTX $14.00
- ERNA N/A
- AVG Volume (30 Days)
- XRTX 125.9K
- ERNA 64.3K
- Earning Date
- XRTX 11-14-2024
- ERNA 11-11-2024
- Dividend Yield
- XRTX N/A
- ERNA N/A
- EPS Growth
- XRTX N/A
- ERNA N/A
- EPS
- XRTX N/A
- ERNA N/A
- Revenue
- XRTX N/A
- ERNA $162,000.00
- Revenue This Year
- XRTX N/A
- ERNA N/A
- Revenue Next Year
- XRTX N/A
- ERNA N/A
- P/E Ratio
- XRTX N/A
- ERNA N/A
- Revenue Growth
- XRTX N/A
- ERNA N/A
- 52 Week Low
- XRTX $1.09
- ERNA $0.84
- 52 Week High
- XRTX $67.72
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- XRTX 53.06
- ERNA 40.96
- Support Level
- XRTX $1.52
- ERNA $1.05
- Resistance Level
- XRTX $2.51
- ERNA $1.19
- Average True Range (ATR)
- XRTX 0.28
- ERNA 0.13
- MACD
- XRTX 0.04
- ERNA 0.03
- Stochastic Oscillator
- XRTX 31.00
- ERNA 51.61
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.